17 percent rise in Sulzer core divisions order intake 2001

11.02.2002

Sulzer Pumps order intake rose by 13% to CHF 984 million (adjusted: +8%). Due to the varying developments in individual market segments, only modest growth is expected for 2002. Strategic focus for the year will mainly be on operational improvements.

Order intake for 2001 by the Sulzer core divisions rose 17% to CHF 1921 million, equivalent to a 7% increase adjusted for acquisitions, divestitures and currency effects. Due to declining figures among the discontinuing operations, overall order intake (not including Sulzer Medica) was 22% lower than in prior year or 1% higher after adjustment. Sulzer expects ongoing growth for 2002 despite a challenging year.

All four Sulzer core divisions attained their goals for 2001 with a 2-digit increase in order intake. The average growth of 7% after adjustments – encouragingly high for such an eventful and demanding year – provides a stable basis for ongoing development in 2002. The global turbulence affected the fourth quarter 2001, the dynamic growth of prior months could not be maintained.

More articles on this topic

GEA Achieves Mid-Term Financial Targets Ahead of Schedule and Announces Ambitious Plans for 2030

07.10.2024 -

GEA recently unveiled its Mission 30 Group strategy at a Capital Markets Day. The comprehensive plan details how GEA will continue to drive profitable growth and significantly expand the company’s share of sustainable solutions until 2030. AI-supported processes and new business models will play an increasingly important role in achieving this.

Read more

Evonik Aims to Generate €1.5 Billion Additional Sales with New Innovation Strategy

26.09.2024 -

Specialty chemicals company Evonik is driving forward the green transformation of industry. With its new innovation strategy, it is stepping up its focus on sustainability. To this end, it is bundling a large proportion of its R&D activities in three new innovation growth areas. These should generate additional sales of €1.5 billion by 2032, compared with 2023.

Read more

Xylem Expands Corporate Venture Capital Investments

17.07.2024 -

Xylem (XYL) is expanding its corporate venture investing plans with $50 million committed to support emerging companies and water services providers that solve critical climate challenges such as water scarcity, quality, and decarbonization. Xylem aims to accelerate the availability of water solutions to address these challenges by directly investing in startups developing disruptive water technologies, and by investing in specialty venture capital funds.

Read more

Record Figures at KSB’s Annual General Meeting

23.05.2024 -

In 2023, the Frankenthal-based pump and valve manufacturer KSB achieved its highest ever order intake and sales revenue. At 7.9 %, the EBIT margin exceeded its expectations for the financial year. At the Annual General Meeting on 8 May, Dr Bernd Flohr, Chairman of the Supervisory Board, expressed his satisfaction in view of the persistently difficult economic conditions.

Read more